Cantrell Drug Company recalls Atropine Sulfate Injection Solution, 0.4 mg/1 mL (0.4 mg/mL), in a) 1 mL syringes and b) 2 mL syringes, Rx Only, Cantre…
- Recall date
- August 21, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1153-2016
- FDA classification
- Class I
- Brand / firm
- Cantrell Drug Company
- Sold / distributed
- Nationwide
Why it was recalled
Subpotent Drug
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
Atropine Sulfate Injection Solution, 0.4 mg/1 mL (0.4 mg/mL), in a) 1 mL syringes and b) 2 mL syringes, Rx Only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-010-45, UPC: 0100352533010453
Get recall alerts
Free email alert whenever Cantrell Drug Company has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Cantrell Drug Company